# Zheng‐Yi Zhou

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/zheng-yi-zhou/

## Facts

| Field | Value |
| --- | --- |
| Citations | 1,788 |
| Field | Multiple Myeloma Research and Treatments |
| h-index | 22 |
| i10-index | 39 |
| Last Known Institution | Health Economics and Outcomes Research (United Kingdom) |
| OpenAlex ID | https://openalex.org/A5101711094 |
| ORCID iD | 0000-0001-9014-8479 |
| Works | 165 |

## Researcher papers

Showing 12 of 14.

- [Economic Impact of Next-Generation Sequencing Versus Single-Gene Testing to Detect Genomic Alterations in Metastatic Non–Small-Cell Lung Cancer Using a Decision Analytic Model](https://scholariq.org/papers/economic-impact-of-next-generation-sequencing-versus-single-gene-testing-to/)
- [Racial disparities in treatment patterns and outcomes among patients with multiple myeloma: a SEER-Medicare analysis](https://scholariq.org/papers/racial-disparities-in-treatment-patterns-and-outcomes-among-patients-with/)
- [Burden of illness: direct and indirect costs among persons with hemophilia A in the United States](https://scholariq.org/papers/burden-of-illness-direct-and-indirect-costs-among-persons-with-hemophilia-a-in/)
- [Risk of developing colorectal cancer and benign colorectal neoplasm in patients with chronic constipation](https://scholariq.org/papers/risk-of-developing-colorectal-cancer-and-benign-colorectal-neoplasm-in-patients/)
- [Overexpression of a Malus baccata NAC Transcription Factor Gene MbNAC25 Increases Cold and Salinity Tolerance in Arabidopsis](https://scholariq.org/papers/overexpression-of-a-malus-baccata-nac-transcription-factor-gene-mbnac25/)
- [Investigation of Adverse-Event-Related Costs for Patients With Metastatic Breast Cancer in a Real-World Setting](https://scholariq.org/papers/investigation-of-adverse-event-related-costs-for-patients-with-metastatic-breast/)
- [Costs of Care in Hemophilia and Possible Implications of Health Care Reform](https://scholariq.org/papers/costs-of-care-in-hemophilia-and-possible-implications-of-health-care-reform/)
- [First-Line Nivolumab Plus Relatlimab Versus Nivolumab Plus Ipilimumab in Advanced Melanoma: An Indirect Treatment Comparison Using RELATIVITY-047 and CheckMate 067 Trial Data](https://scholariq.org/papers/first-line-nivolumab-plus-relatlimab-versus-nivolumab-plus-ipilimumab-in/)
- [The effects of environmental provisions in RTAs on PM2.5 air pollution](https://scholariq.org/papers/the-effects-of-environmental-provisions-in-rtas-on-pm2-5-air-pollution/)
- [Comparative Efficacy of Ceritinib and Crizotinib as Initial ALK –Targeted Therapies in Previously Treated Advanced NSCLC: An Adjusted Comparison with External Controls](https://scholariq.org/papers/comparative-efficacy-of-ceritinib-and-crizotinib-as-initial-alk-targeted/)
- [Kidney Failure Attributed to Focal Segmental Glomerulosclerosis: A USRDS Retrospective Cohort Study of Epidemiology, Treatment Modalities, and Economic Burden](https://scholariq.org/papers/kidney-failure-attributed-to-focal-segmental-glomerulosclerosis-a-usrds/)
- [Kidney Failure Attributed to Immunoglobulin A Nephropathy: A USRDS Retrospective Cohort Study of Epidemiology, Treatment Modalities, and Economic Burden](https://scholariq.org/papers/kidney-failure-attributed-to-immunoglobulin-a-nephropathy-a-usrds-retrospective/)

## Researcher topics

- [Multiple Myeloma Research and Treatments](https://scholariq.org/topics/multiple-myeloma-research-and-treatments/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Economic and Financial Impacts of Cancer](https://scholariq.org/topics/economic-and-financial-impacts-of-cancer/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)

## Researcher university

- [Health Economics and Outcomes Research (United Kingdom)](https://scholariq.org/institutions/health-economics-and-outcomes-research-united-kingdom/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.